|
|
|
Volumn 88, Issue 9, 2003, Pages 961-973
|
|
Strategies to reduce the burden of venous thromboembolism
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ALTEPLASE;
BLOOD CLOTTING FACTOR 10A INHIBITOR;
DALTEPARIN;
DANAPAROID;
ENOXAPARIN;
FONDAPARINUX;
HEPARIN;
LOW MOLECULAR WEIGHT HEPARIN;
MELAGATRAN;
NADROPARIN;
STREPTOKINASE;
TINZAPARIN;
TISSUE FACTOR PATHWAY INHIBITOR;
UROKINASE;
WARFARIN;
XIMELAGATRAN;
ANTICOAGULATION;
BLEEDING;
DEEP VEIN THROMBOSIS;
DISEASE COURSE;
DRUG SAFETY;
FATALITY;
GASTROINTESTINAL HEMORRHAGE;
HIGH RISK PATIENT;
HUMAN;
HYPERCOAGULABILITY;
LUNG EMBOLISM;
MORBIDITY;
MORTALITY;
RECURRENCE RISK;
REVIEW;
RISK BENEFIT ANALYSIS;
RISK FACTOR;
THROMBOCYTOPENIA;
THROMBOEMBOLISM;
THROMBOGENESIS;
TREATMENT INDICATION;
VEIN THROMBOSIS;
HUMANS;
RISK ASSESSMENT;
RISK MANAGEMENT;
THROMBOEMBOLISM;
VENOUS THROMBOSIS;
|
|
EID: 0141813583
PISSN: 03906078
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (2)
|
|
References (0)
|
